United Capital Financial Advisers, LLC Bristol Myers Squibb CO Transaction History

United Capital Financial Advisers, LLC

$12 Billion
Q1 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 199,983 shares of BMY stock, worth $7.93 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

199,983

Previous 192,797 3.73%

Holding current value

$7.93 Million

Previous $9.89 Million 9.63%

% of portfolio

0.09%

Previous 0.08%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $344,784 - $390,918	7,186 Added 3.73%	199,983 $10.8 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $13.3 Million - $15.8 Million	-273,772 Reduced 58.68%	192,797 $9.89 Million
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $1.47 Million - $1.65 Million	-25,476 Reduced 5.18%	466,569 $27.1 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $2.38 Million - $2.64 Million	-37,372 Reduced 7.06%	492,045 $31.5 Million
Q1 2023 Aug 14, 2023	BUY	$65.71 - $74.53 $1.45 Million - $1.65 Million	22,105 Added 4.49%	514,150 $35.6 Million

Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $948,523 - $1.08 Million	14,435 Added 2.8%	529,417 $36.7 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $315,624 - $373,743	-4,609 Reduced 0.89%	514,982 $37 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $2,617 - $1.55 Million	-20,134 Reduced 3.73%	519,591 $36.9 Million
Q2 2022 Aug 11, 2022	BUY	$72.62 - $79.98 $819,516 - $902,574	11,285 Added 2.14%	539,725 $41.6 Million
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $561,189 - $672,916	-9,128 Reduced 1.7%	528,440 $38.6 Million
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $2.65 Million - $3.09 Million	-49,424 Reduced 8.42%	537,568 $33.5 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $700,572 - $820,630	-11,840 Reduced 1.98%	586,992 $34.7 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $579,106 - $630,646	-9,354 Reduced 1.54%	598,832 $40 Million
Q1 2021 May 14, 2021	BUY	$59.34 - $66.74 $39,045 - $43,914	658 Added 0.11%	608,186 $38.4 Million
Q4 2020 Feb 17, 2021	SELL	$57.74 - $65.43 $713,550 - $808,583	-12,358 Reduced 1.99%	607,528 $37.7 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $727,178 - $805,809	-12,662 Reduced 2.0%	619,886 $37.4 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $4.24 Million - $4.95 Million	-77,260 Reduced 10.88%	632,548 $37.2 Million
Q1 2020 May 15, 2020	BUY	$46.4 - $67.43 $2.41 Million - $3.5 Million	51,943 Added 7.9%	709,808 $39.6 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $7.83 Million - $10.2 Million	159,113 Added 31.9%	657,865 $42.2 Million
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $16.9 Million - $20 Million	-394,623 Reduced 44.17%	498,752 $25.3 Million
Q2 2019 Aug 13, 2019	BUY	$44.62 - $49.34 $17 Million - $18.8 Million	380,918 Added 74.33%	893,375 $40.5 Million
Q1 2019 May 14, 2019	BUY	$45.12 - $53.8 $7.14 Million - $8.51 Million	158,233 Added 44.67%	512,457 $24.4 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $916,639 - $1.19 Million	-18,799 Reduced 5.04%	354,224 $18.4 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $373,746 - $421,557	-6,772 Reduced 1.78%	373,023 $23.2 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $1.78 Million - $2.22 Million	-35,175 Reduced 8.48%	379,795 $21 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $1.65 Million - $1.9 Million	27,567 Added 7.12%	414,970 $26.2 Million
Q4 2017 Feb 13, 2018	BUY	$59.94 - $65.35 $583,995 - $636,705	9,743 Added 2.58%	387,403 $23.9 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $5.35 Million - $6.17 Million	96,827 Added 34.48%	377,660 $24.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	280,833	280,833 $15.6 Million

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $84.3B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account

United Capital Financial Advisers, LLC Bristol Myers Squibb CO Transaction History